Table 3.
Frequency of cancer-related characteristics of English- and Spanish-language patients with cancer and survivors responding to at least 50% of the Cook for Your Life website survey stratified by gender.
| Characteristic | English respondents (n=1394), n (%) | Spanish respondents (n=81), n (%) | ||||||||
| Male (n=201) | Female (n=1177) | Male (n=13) | Female (n=67) | |||||||
| Primary cancer site | ||||||||||
|
|
Breast | 0 (0) | 624 (53.0) | 0 (0) | 27 (40.3) |
|
||||
|
|
Gastrointestinal region | 64 (31.8) | 142 (12.1) | 4 (30.8) | 11 (16.4) |
|
||||
|
|
Gynecologic region | N/Aa | 124 (10.5) | N/Aa | 10 (14.9) |
|
||||
|
|
Hematologic region | 24 (11.9) | 102 (8.7) | 0 (0) | 1 (1.5) |
|
||||
|
|
Genitourinary region | 57 (28.4) | 26 (2.2) | 4 (30.8) | 3 (4.5) |
|
||||
|
|
Respiratory region (lung) | 10 (5.0) | 29 (2.5) | 1 (7.7) | 3 (4.5) |
|
||||
|
|
Skin | 6 (3.0) | 24 (2.0) | 1 (7.7) | 2 (3.0) |
|
||||
|
|
Endocrine region (thyroid) | 1 (0.5) | 20 (1.7) | 3 (23.1) | 3 (4.5) |
|
||||
|
|
Other | 39 (19.4) | 86 (7.3) | 0 (0) | 7 (10.5) |
|
||||
| Age at diagnosis (years) | ||||||||||
|
|
18-35 | 8 (4.0) | 62 (5.3) | 1 (7.7) | 10 (14.9) |
|
||||
|
|
36-55 | 38 (18.9) | 477 (40.5) | 6 (46.2) | 32 (47.8) |
|
||||
|
|
56-65 | 50 (24.9) | 355 (30.2) | 2 (15.4) | 16 (23.9) |
|
||||
|
|
>65 | 105 (52.2) | 283 (24.0) | 4 (30.8) | 9 (13.4) |
|
||||
| Undergoing treatment | 111 (55.2) | 581 (49.4) | 11 (84.6) | 26 (38.8) | ||||||
| Type of treatment (out of those undergoing treatment, as reflected in “Total” row) | ||||||||||
|
|
Total | 111 (100) | 581 (100) | 11 (100) | 26 (100) |
|
||||
|
|
Chemotherapy | 78 (70.3) | 274 (47.2) | 4 (36.4) | 13 (50.0) |
|
||||
|
|
Radiation therapy | 24 (21.6) | 102 (17.6) | 3 (27.3) | 5 (19.2) |
|
||||
|
|
Endocrine therapy | 9 (8.1) | 183 (31.5) | 4 (36.4) | 7 (26.9) |
|
||||
|
|
Targeted therapy or immunotherapy | 18 (16.2) | 125 (21.5) | 0 (0) | 2 (7.7) |
|
||||
|
|
Surgery | 64 (57.7) | 467 (80.4) | 11 (100) | 12 (46.2) |
|
||||
| Side effects in past 7 daysb (out of those with side effects, as reflected in “Total” row) | ||||||||||
|
|
Total | 111 (100) | 581 (100) | 11 (100) | 26 (100) |
|
||||
|
|
Fatigue | 72 (64.9) | 373 (64.2) | 3 (27.3) | 13 (50.0) |
|
||||
|
|
Anxiety | 27 (24.3) | 201 (34.6) | 4 (36.4) | 10 (38.5) |
|
||||
|
|
Insomnia | 20 (18.0) | 190 (32.7) | 2 (18.2) | 12 (46.2) |
|
||||
|
|
Sad feelings | 35 (31.5) | 169 (29.1) | 4 (36.4) | 11 (42.3) |
|
||||
|
|
Nausea | 33 (29.7) | 159 (27.4) | 3 (27.3) | 12 (46.2) |
|
||||
|
|
Dry mouth | 24 (21.6) | 165 (28.4) | 1 (9.1) | 9 (34.6) |
|
||||
|
|
Hot flashes | 7 (6.3) | 181 (31.2) | 2 (18.2) | 11 (42.3) |
|
||||
|
|
Decreased appetite | 39 (35.1) | 146 (25.1) | 3 (27.3) | 9 (34.6) |
|
||||
|
|
General pain | 22 (19.8) | 151 (26.0) | 4 (36.4) | 7 (26.9) |
|
||||
|
|
Taste changes | 30 (27.0) | 142 (24.4) | 1 (9.1) | 8 (30.8) |
|
||||
|
|
Constipation | 23 (20.7) | 143 (24.6) | 2 (18.2) | 8 (30.8) |
|
||||
|
|
Diarrhea | 23 (20.7) | 130 (22.4) | 2 (18.2) | 2 (7.7) |
|
||||
|
|
Mouth sores | 6 (5.4) | 62 (10.7) | 1 (9.1) | 3 (11.5) |
|
||||
|
|
Difficulty swallowing | 16 (14.4) | 40 (6.9) | 1 (9.1) | 5 (19.2) |
|
||||
|
|
Vomiting | 9 (8.1) | 34 (5.9) | 0 (0) | 4 (15.4) |
|
||||
aN/A: not applicable for men.
bMultiple responses possible.